Startup Spotlight: Meridian Diagnostics — Bringing Rapid TB Detection to Low-Resource Settings
Enventure's research team supported Meridian Diagnostics in validating their market opportunity across three continents. Here's their story.
The Problem
Tuberculosis kills over 1.3 million people annually, yet diagnosis in low-resource settings remains slow, expensive, and unreliable. Meridian Diagnostics is changing that with a rapid point-of-care test deployable in under 20 minutes.
The Enventure Engagement
Meridian's founding team partnered with Enventure for a 4-week market research sprint. Our team — led by two global health PhD candidates — delivered:
- A total addressable market analysis across Sub-Saharan Africa, South Asia, and Southeast Asia
- Regulatory pathway comparison across target geographies
- A competitive landscape identifying 6 key competitors and their positioning gaps
The Impact
"Enventure gave us research-grade market intelligence at a cost that made sense for a pre-seed company," says Meridian's CEO. "Their team understood the science immediately — that was the difference."
Written by
Ask a question to start the discussion — try "What are the key takeaways?" or "How does this relate to TMC startups?"